Early Diagnosis and Multidisciplinary Care Reduce the Hospitalization Time and Duration of Tube Feeding and Prevent Early Obesity in PWS Infants
- 1 December 2007
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 69 (1), 45-52
- https://doi.org/10.1159/000111795
Abstract
Background/Aims: To describe and evaluate the impact of very early diagnosis and multidisciplinary care on the evolution and care of infants presenting with Prader-Willi syndrome (PWS). Methods: 19 infants diagnosed with PWS before the second month of life were followed by a multidisciplinary team. Median age at the time of analysis was 3.1 years [range 0.4–6.5]. The data were compared with data collected in 1997 from 113 questionnaires filled out by members of the French PWS Association. The patients from this latter data set were 12.0 years [range 4 months to 41 years] at the time of analysis, with a median age of 36 months at diagnosis. Results: The duration of their hospitalization time was significantly reduced from 30.0 [range 0–670] to 21 [range 0–90] days (p = 0.043). The duration of gastric tube feeding was significantly reduced from 30.5 [range 0–427] to 15 [range 0–60] days (p = 0.017). Growth hormone treatment was started at a mean age of 1.9 ± 0.5 years in 10 infants and L-thyroxine in 6 infants. Only 1 infant became obese at 2.5 years. Conclusion: Early diagnosis combined with multidisciplinary care decreases the hospitalization time, duration of gastric tube feeding and prevents early obesity in PWS infants.Keywords
This publication has 22 references indexed in Scilit:
- Neonatal hypotonia: don't forget the Prader-Willi syndromeActa Paediatrica, 2007
- Deaths in Children with Prader-Willi SyndromeHormone Research in Paediatrics, 2005
- Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndromeThe Journal of Pediatrics, 2004
- Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in FlandersEuropean Journal of Human Genetics, 2003
- Birth prevalence of Prader-Willi syndrome in AustraliaArchives of Disease in Childhood, 2003
- Benefits of Long-Term GH Therapy in Prader-Willi Syndrome: A 4-Year StudyJournal of Clinical Endocrinology & Metabolism, 2002
- Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GHEndocrine Reviews, 2001
- Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health RegionJournal of Medical Genetics, 2001
- A clinical, cytogenetic, and molecular study of 40 adults with the Prader-Willi syndrome.Journal of Medical Genetics, 1995
- Growth Hormone (GH) Response to Combined Pyridostigmine and GH-Releasing Hormone Administration in Patients with Prader-Labhard-Willi SyndromeHormone Research, 1993